Equity (Details) - Schedule of warrants outstanding |
9 Months Ended |
|---|---|
|
Mar. 31, 2021
$ / shares
shares
| |
| 2020 warrants [Member] | |
| Equity (Details) - Schedule of warrants outstanding [Line Items] | |
| Warrants Exercisable | shares | 1,807,000 |
| Weighted Average Exercise Price | $ / shares | $ 2.085 |
| Average Remaining Contractual Life | 4 years 153 days |
| 2021 warrants [Member] | |
| Equity (Details) - Schedule of warrants outstanding [Line Items] | |
| Warrants Exercisable | shares | 10,808,280 |
| Weighted Average Exercise Price | $ / shares | $ 6.234 |
| Average Remaining Contractual Life | 5 years 65 days |
| 2018 Series A [Member] | |
| Equity (Details) - Schedule of warrants outstanding [Line Items] | |
| Warrants Exercisable | shares | 363,334 |
| Weighted Average Exercise Price | $ / shares | $ 8.75 |
| Average Remaining Contractual Life | 2 years 164 days |